Neuroone Medical Technologies Stock Probability of Future Stock Price Finishing Under 1.03
| NMTC Stock | USD 0.76 0.02 2.70% |
Neuroone |
Neuroone Medical Target Price Odds to finish below 1.03
The tendency of Neuroone Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.03 after 90 days |
| 0.76 | 90 days | 1.03 | about 91.65 |
Based on a normal probability distribution, the odds of Neuroone Medical to stay under $ 1.03 after 90 days from now is about 91.65 (This Neuroone Medical Technologies probability density function shows the probability of Neuroone Stock to fall within a particular range of prices over 90 days) . Probability of Neuroone Medical Tec price to stay between its current price of $ 0.76 and $ 1.03 at the end of the 90-day period is about 67.25 .
Given the investment horizon of 90 days Neuroone Medical has a beta of 0.73. This indicates as returns on the market go up, Neuroone Medical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Neuroone Medical Technologies will be expected to be much smaller as well. Additionally Neuroone Medical Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Neuroone Medical Price Density |
| Price |
Predictive Modules for Neuroone Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neuroone Medical Tec. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuroone Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Neuroone Medical is not an exception. The market had few large corrections towards the Neuroone Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neuroone Medical Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neuroone Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 0.73 | |
σ | Overall volatility | 0.13 | |
Ir | Information ratio | -0.04 |
Neuroone Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neuroone Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neuroone Medical Tec can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Neuroone Medical Tec generated a negative expected return over the last 90 days | |
| Neuroone Medical Tec has high historical volatility and very poor performance | |
| Neuroone Medical Tec has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 3.45 M. Net Loss for the year was (12.32 M) with loss before overhead, payroll, taxes, and interest of (3.05 M). | |
| Neuroone Medical Technologies currently holds about 10.18 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Neuroone Medical Tec has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from insidermonkey.com: NeuroOne Medical Technologies Corporation Q4 2024 Earnings Call Transcript |
Neuroone Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neuroone Stock often depends not only on the future outlook of the current and potential Neuroone Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuroone Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.8 M | |
| Cash And Short Term Investments | 1.5 M |
Neuroone Medical Technical Analysis
Neuroone Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Neuroone Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neuroone Medical Technologies. In general, you should focus on analyzing Neuroone Stock price patterns and their correlations with different microeconomic environments and drivers.
Neuroone Medical Predictive Forecast Models
Neuroone Medical's time-series forecasting models is one of many Neuroone Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Neuroone Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Neuroone Medical Tec
Checking the ongoing alerts about Neuroone Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Neuroone Medical Tec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Neuroone Medical Tec generated a negative expected return over the last 90 days | |
| Neuroone Medical Tec has high historical volatility and very poor performance | |
| Neuroone Medical Tec has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 3.45 M. Net Loss for the year was (12.32 M) with loss before overhead, payroll, taxes, and interest of (3.05 M). | |
| Neuroone Medical Technologies currently holds about 10.18 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Neuroone Medical Tec has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from insidermonkey.com: NeuroOne Medical Technologies Corporation Q4 2024 Earnings Call Transcript |
Check out Neuroone Medical Backtesting, Neuroone Medical Valuation, Neuroone Medical Correlation, Neuroone Medical Hype Analysis, Neuroone Medical Volatility, Neuroone Medical History as well as Neuroone Medical Performance. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.158 | Quarterly Revenue Growth 0.311 | Return On Assets (1.43) | Return On Equity (3.49) |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.